SCHEDULE TO Software License, Customization and Maintenance Agreement Supplier Name: Cardlytics, Inc. Agreement Number: CW251207 Supplier Address: 621 North Avenue NE Suite C-30 Atlanta, GA 30308 Addendum Number: CW255039 Supplier Telephone: 888.798.5802 Addendum Effective Date March 3, 2011 This Schedule (“Schedule”) is made as of the effective date set forth above to that Software License, Customization, and Maintenance Agreement, by and between Cardlytics, Inc. (“Supplier”) and Bank of America, N. A, (“Bank of America”), dated November 5, 2010, as amended (“SLCMA”). <*$p$*>Each capitalized term used but not defined herein shall have the meaning assigned in the SLCMA, except for the term 'Software'. 'Software' in this Schedule refers only to the Supplier Offer Placement System Software and not any other software referenced in the SLCMA.<*$p$*> <*$p$*>WHEREAS, Bank of America and Supplier entered into the SLCMA in order to set forth the terms and conditions pursuant to which Supplier provides certain Software to Bank of America, WHEREAS, the parties desire to supersede the software provisions of the SLCMA entirely with this Schedule regarding the Supplier Offer Placement System Software;<*$p$*> NOW THEREFORE, in consideration of the promises and accords made herein, and the exchange of such good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Bank of America and Supplier agree as follows: <*$p$*>The attached Schedule [A] is hereby incorporated into the SLCMA describing the Offer Placement System Software for use by Bank of America. However, this Schedule shall be treated as a completely separate agreement, independent of the SLCMA, regarding the Offer Placement System Software.<*$p$*> THE FOREGOING IS UNDERSTOOD AND AGREED TO BY: Cardlytics, Inc. (“Supplier”) Bank of America, N.A. (“Bank of America”) By: /s/ Scott Grimes By: /s/ Chandra Torrence Name: Scott Grimes Name: Chandra Torrence Title: Chief Executive Officer Title: V.P., Sourcing Manager Date: 3/4/11 Date: 3/3/11 1. Source: CARDLYTICS, INC., S-1, 1/12/2018